0001209191-20-054372.txt : 20201008 0001209191-20-054372.hdr.sgml : 20201008 20201008210304 ACCESSION NUMBER: 0001209191-20-054372 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201008 FILED AS OF DATE: 20201008 DATE AS OF CHANGE: 20201008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gharib Samir M. CENTRAL INDEX KEY: 0001533302 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 201231926 MAIL ADDRESS: STREET 1: 2655 PINE STREET STREET 2: #6 CITY: SAN FRANCISCO STATE: CA ZIP: 94115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 294-1687 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-08 0 0001683553 SPRUCE BIOSCIENCES, INC. SPRB 0001533302 Gharib Samir M. 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 DALY CITY CA 94014 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.64 2030-06-07 Common Stock 118483 D Stock Option (Right to Buy) 3.07 2030-08-06 Common Stock 71548 D The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing May 1, 2020, with 1/4th of the shares vesting on May 1, 2021 and 1/36th of the remaining shares vesting on a monthly basis. The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing August 7,2020, with 1/48th of the shares vesting on a monthly basis. /s/ Samir Gharib 2020-10-08